Literature DB >> 1335662

Epidemiology of hepatitis A in Mediterranean countries.

G Papaevangelou1.   

Abstract

Infection with hepatitis A virus (HAV) is still endemic in some Mediterranean areas. In most Northern Mediterranean countries, the incidence of acute icteric hepatitis in adults is increasing. This is due to the shifting of HAV infection to adulthood as a result of the decline of its overall prevalence due to improvements in socioeconomic, sanitary and hygienic conditions. The majority of adults remain susceptible and develop overt disease when infected, since the severity of disease is highly associated with age. Epidemics are now rare, but are more extensive when they do occur. They may sometimes be caused by accidental contamination of the water supply, but are usually due to contamination of food by diseased food-handlers or result from contaminated frozen foods. Outbreaks still may occur in day-care centres and in schools. Thus travelling to endemic areas is becoming the main source of HAV infection. Intrafamilial person-to-person spread also is an important source of infection. Transmission from children to parents and other adults may occur due to lack of immunity in the adult population. Selective immunization would further reduce the incidence of the disease. However, only inclusion of the vaccine in the routine programme of childhood immunization would guarantee the disappearance of hepatitis A.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1335662     DOI: 10.1016/0264-410x(92)90546-v

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  21 in total

1.  Prevalence of antibodies to hepatitis A among children and adolescents in Larnaca area, Cyprus.

Authors:  A Hadjipanayis; C Hadjichristodoulou; M Kallias; K Sava; A Petsa; K Demetriadou; C Christodoulou; A Constantinou; M Sidera
Journal:  Eur J Epidemiol       Date:  1999-11       Impact factor: 8.082

2.  Hepatitis A seroprevalence in Slovene travellers.

Authors:  M Socan; A Kraigher; N Fiser-Marinic
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

3.  Prevalence of hepatitis A, B, and C markers in school children of a rural area of Crete, Greece.

Authors:  C Lionis; E Frangoulis; M Koulentakis; E Biziagos; E Kouroumalis
Journal:  Eur J Epidemiol       Date:  1997-06       Impact factor: 8.082

4.  Prevalence of anti-HAV antibodies in multitransfused patients with beta-thalassemia.

Authors:  Dimitrios Siagris; Alexandra Kouraklis-Symeonidis; Irini Konstantinidou; Myrto Christofidou; Ioannis Starakis; Alexandra Lekkou; Christos Papadimitriou; Alexandros Blikas; Nicholas Zoumbos; Chryssoula Labropoulou-Karatza
Journal:  World J Gastroenterol       Date:  2008-03-14       Impact factor: 5.742

5.  Hepatitis A infection: a seroepidemiological study in young adults in North-East Italy.

Authors:  M E Moschen; A Floreani; E Zamparo; V Baldo; S Majori; V Gasparini; R Trivello
Journal:  Eur J Epidemiol       Date:  1997-12       Impact factor: 8.082

6.  Prevalence of hepatitis A antibodies in food handlers in Italy.

Authors:  I F Angelillo; C G Nobile; F Talarico; M Pavia
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

7.  Age-specific seroepidemiology of hepatitis A, B, and E infections among children in Istanbul, Turkey.

Authors:  M Sidal; E Unüvar; F Oğuz; C Cihan; D Onel; S Badur
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

8.  Seroprevalence of hepatitis A virus infection among sewage workers in the Parisian area, France.

Authors:  P Cadilhac; F Roudot-Thoraval
Journal:  Eur J Epidemiol       Date:  1996-06       Impact factor: 8.082

9.  Prevalence of hepatitis A antibody among disadvantaged gypsy children in northern Spain.

Authors:  G Cilla; E Perez-Trallero; J M Marimon; S Erdozain; C Gutierrez
Journal:  Epidemiol Infect       Date:  1995-08       Impact factor: 2.451

10.  Age-specific seroprevalence of hepatitis A infection among children visited in pediatric hospitals of Tehran, Iran.

Authors:  Ali Jafari Mehr; Mohammad Javad Ehsani Ardakani; Mehdi Hedayati; Saeed Shahraz; Elnaz Jafari Mehr; Mohammad Reza Zali
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.